China National Pharmaceutical Group Corporation (Sinopharm)
Establishment time : 1998
website : www.sinopharm.com
Main Product : pharmaceuticals, vaccines, medical devices
Company Profile
China National Pharmaceutical Group Corporation (Sinopharm) is a state-owned enterprise that specializes in pharmaceuticals, vaccines, and medical devices. With a history dating back to 1998, Sinopharm has grown to become one of the largest pharmaceutical companies in China, with a wide range of products and a strong presence in both domestic and international markets. The company is known for its high-quality products and commitment to innovation in the healthcare industry.
Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd.
Establishment time : 1998
website : www.tianyuanbio.com
Main Product : Heparin Sodium, Enoxaparin Sodium, Hyaluronic Acid
Company Profile
Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd. is a reputable pharmaceutical company founded in 1998. We specialize in the production of heparin sodium, enoxaparin sodium, and hyaluronic acid. With a medium-sized company size, we have established a strong presence in both domestic and international markets. Our competitive situation is solid, as we are recognized as a leading manufacturer in the pharmaceutical industry with a strong foothold in the global market. Visit our website at www.tianyuanbio.com for more information.
Hualan Biological Engineering Inc.
Establishment time : 1998
website : www.hualanbio.com
Main Product : vaccines, blood products, diagnostic reagents
Company Profile
Hualan Biological Engineering Inc. was founded in 1998 and has established itself as a leading biopharmaceutical company in China. With a focus on vaccines, blood products, and diagnostic reagents, the company has a strong presence in markets across China, Southeast Asia, the Middle East, and Africa. With over 1000 employees, Hualan Biological Engineering Inc. is known for its strong R&D capabilities and commitment to innovation in the field of biological engineering. Visit their website at www.hualanbio.com for more information.
Changchun Zhuoyi Biological Co., Ltd
Company Profile
Changchun Zhuoyi Biological Co., Ltd., located in Shuangyang Economic Development Zone of Changchun City, is a key vaccine manufacturer invested by Zhejiang SelCorning Biotechnology Co., Ltd. in Jilin Province, and a vice chairman unit of Zhejiang Chamber of Commerce in Jilin Province. The company was founded on January 27, 2005. Mr. Feng Xingfu, chairman and general manager of the company, graduated from the Department of Biology, University of Science and Technology of China, and has been engaged in the marketing and enterprise management of biological products since the 1980s. The company has a registered capital of one hundred and one million six hundred and ninety-two thousand seven hundred and eighty-four yuan, covers an area of 41600 square meters, and has the leading vaccine research and development and production capacity in China. Changchun Zhuoyi Biological Co., Ltd. is a new vaccine manufacturer integrating R&D, production and sales. At present, the biological products approved by the company are mainly Rabies Vaccine (Vero cell) for Human Use, Freeze-dried. The company successfully passed the two in one inspection at the end of 2016 and obtained the registration approval and GMP certificate, which was officially put into production in January 2017. The company's existing production workshop covers an area of about 5700 square meters, with a cumulative investment of 400 million yuan. At present, the maximum annual output is 1 million people. The second phase workshop has been completed at the end of 2018, and will be officially produced in 2020. By then, the production capacity can reach 4 million people. The company has nearly 2000 square meters of pilot scale research workshop, advanced equipment such as bioreactor, ultrafiltration system, AKTA purification workstation, fluorescence microscope, etc., which are used for virus culture, improvement of purification system and identification of recombinant protein. The company has maintained close scientific research cooperation with many scientific research institutions at home and abroad. At present, the company is developing a serum rabies vaccine and a broad-spectrum human papillomavirus vaccine jointly developed with the Institute of Basic Medicine of the Chinese Academy of Medical Sciences. It is planned to cooperate with Murdoch Children's Research Institute in Australia to develop the round vaccine project. At the same time, the company also actively explores the path of internationalization. At present, the company has started to register in the Philippines, Pakistan, Cambodia, Bangladesh, Mongolia, Uzbekistan and other countries. It is estimated that the export of finished products in some markets will be realized by 2020. The company's technical cooperation project with Australia is one of the company's many international cooperation projects. The company always adheres to the concept of "standardized management, quality first", and adheres to the core values of "honesty, diligence, innovation, preciseness, learning and happiness", so as to provide high-quality vaccine products to serve the health of the people.
Changchun Institute of Biological Products
Establishment time : 1943
website : http://www.cibp.cnbio.com/
Main Product : vaccines, biological products
Company Profile
Changchun Institute of Biological Products is a renowned biopharmaceutical company that specializes in the research, development, and production of vaccines and biological products. With a history dating back to 1943, the company has grown to become a key player in the healthcare industry, providing high-quality products to customers in China and around the world.
Shenzhen Kangtai Biological Products Co., Ltd.
Establishment time : 1992
website : www.kangtaibio.com
Main Product : Vaccines, blood products, and other biological products
Company Profile
Shenzhen Kangtai Biological Products Co., Ltd. is a renowned biopharmaceutical company specializing in the research, development, and production of vaccines, blood products, and other biological products. With a history dating back to 1992, the company has grown to become a major player in the industry, serving markets in China, Southeast Asia, Middle East, and Africa. With a large workforce of over 2,000 employees, Kangtai Bio is known for its high-quality products and strong competitive position in the global market. Visit their website at www.kangtaibio.com for more information.
Chengdu Institute of Biological Products Co., Ltd.
Establishment time : 1967
website : http://www.cdibp.com.cn/
Main Product : Vaccines, biological products
Company Profile
Chengdu Institute of Biological Products Co., Ltd. is a renowned biopharmaceutical company established in 1967. It specializes in the production of vaccines and biological products, serving both domestic and international markets. With a large company size and a strong competitive position, it is a key player in the industry. Visit their website for more information.
Wuhan Institute of Biological Products
Establishment time : 1965
website :
Main Product : Vaccines, biological products
Company Profile
Wuhan Institute of Biological Products is a leading biopharmaceutical company in China, specializing in the research, development, and production of vaccines and biological products. Established in 1965, the company has a strong presence in both domestic and international markets, with a focus on providing high-quality and innovative healthcare solutions. With a medium-sized workforce, the company faces competition from other pharmaceutical companies but continues to be a key player in the industry.
